Skip to main content
. 2018 Feb 15;15(4):5497–5504. doi: 10.3892/ol.2018.8062

Figure 3.

Figure 3.

NKp44, NKG2D and DNAM-1 in patients with MDS and healthy controls. (A) The expression of NKp44 on NK cells in patients with MDS and healthy controls. (B) The relative mRNA expression level of NKp44 in purified target NK lymphocytes. (C) The percentage of NKG2D on NK cells of patients with MDS and healthy controls. (D) The expression of DNAM-1 on NK cells in MDS patients and healthy controls. Inhibitory receptors on NK cells were decreased in MDS patients compared with healthy controls. NK, natural killer; NKG2D, NK group 2, member D; DNAM-1, cluster of differentiation 226; MDS, myelodysplastic syndromes.